Pfizer recalls all batches of anti-smoking drug Chantix due to the risk of cancer
Pfizer has announced it has recalled all batches of its popular anti-smoking drug Chantix because of the increased risk of cancer due to high nitrosamine levels, according to a Reuters report. When Pfizer halted distribution of the drug in June, a spokesman said the company believed the drug's benefits outweigh the very low ...
End of content
No more pages to load